Utah Medical Products Gross Margin 2012-2025 | UTMD
Current and historical gross margin for Utah Medical Products (UTMD) over the last 10 years. The current gross profit margin for Utah Medical Products as of September 30, 2025 is %.
| Utah Medical Products Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.04B | $0.02B | 58.97% |
| 2025-06-30 | $0.04B | $0.02B | 58.97% |
| 2025-03-31 | $0.04B | $0.02B | 58.97% |
| 2024-12-31 | $0.04B | $0.02B | 60.00% |
| 2024-09-30 | $0.04B | $0.03B | 60.47% |
| 2024-06-30 | $0.05B | $0.03B | 58.70% |
| 2024-03-31 | $0.05B | $0.03B | 59.18% |
| 2023-12-31 | $0.05B | $0.03B | 58.82% |
| 2023-09-30 | $0.05B | $0.03B | 58.49% |
| 2023-06-30 | $0.05B | $0.03B | 60.38% |
| 2023-03-31 | $0.05B | $0.03B | 60.38% |
| 2022-12-31 | $0.05B | $0.03B | 61.54% |
| 2022-09-30 | $0.05B | $0.03B | 62.75% |
| 2022-06-30 | $0.05B | $0.03B | 62.75% |
| 2022-03-31 | $0.05B | $0.03B | 62.75% |
| 2021-12-31 | $0.05B | $0.03B | 62.00% |
| 2021-09-30 | $0.05B | $0.03B | 61.22% |
| 2021-06-30 | $0.05B | $0.03B | 60.87% |
| 2021-03-31 | $0.04B | $0.03B | 59.52% |
| 2020-12-31 | $0.04B | $0.03B | 59.52% |
| 2020-09-30 | $0.04B | $0.03B | 61.90% |
| 2020-06-30 | $0.04B | $0.03B | 61.36% |
| 2020-03-31 | $0.05B | $0.03B | 63.83% |
| 2019-12-31 | $0.05B | $0.03B | 63.83% |
| 2019-09-30 | $0.05B | $0.03B | 62.22% |
| 2019-06-30 | $0.04B | $0.03B | 62.79% |
| 2019-03-31 | $0.04B | $0.03B | 61.90% |
| 2018-12-31 | $0.04B | $0.03B | 61.90% |
| 2018-09-30 | $0.04B | $0.03B | 61.90% |
| 2018-06-30 | $0.04B | $0.03B | 61.90% |
| 2018-03-31 | $0.04B | $0.03B | 61.90% |
| 2017-12-31 | $0.04B | $0.03B | 63.41% |
| 2017-09-30 | $0.04B | $0.03B | 62.50% |
| 2017-06-30 | $0.04B | $0.03B | 62.50% |
| 2017-03-31 | $0.04B | $0.02B | 61.54% |
| 2016-12-31 | $0.04B | $0.02B | 58.97% |
| 2016-09-30 | $0.04B | $0.02B | 60.00% |
| 2016-06-30 | $0.04B | $0.02B | 60.00% |
| 2016-03-31 | $0.04B | $0.02B | 60.00% |
| 2015-12-31 | $0.04B | $0.02B | 60.00% |
| 2015-09-30 | $0.04B | $0.02B | 60.00% |
| 2015-06-30 | $0.04B | $0.02B | 58.54% |
| 2015-03-31 | $0.04B | $0.02B | 58.54% |
| 2014-12-31 | $0.04B | $0.02B | 58.54% |
| 2014-09-30 | $0.04B | $0.02B | 58.54% |
| 2014-06-30 | $0.04B | $0.02B | 60.00% |
| 2014-03-31 | $0.04B | $0.02B | 60.00% |
| 2013-12-31 | $0.04B | $0.02B | 60.00% |
| 2013-09-30 | $0.04B | $0.02B | 60.00% |
| 2013-06-30 | $0.04B | $0.02B | 60.00% |
| 2013-03-31 | $0.04B | $0.02B | 60.00% |
| 2012-12-31 | $0.04B | $0.03B | 60.98% |
| 2012-09-30 | $0.04B | $0.03B | 60.98% |
| 2012-06-30 | $0.04B | $0.03B | 61.90% |
| 2012-03-31 | $0.04B | $0.03B | 61.90% |
| 2011-12-31 | $0.04B | $0.02B | 60.53% |
| 2011-09-30 | $0.03B | $0.02B | 58.82% |
| 2011-06-30 | $0.03B | $0.02B | 55.17% |
| 2011-03-31 | $0.03B | $0.01B | 52.00% |
| 2010-12-31 | $0.02B | $0.01B | 50.00% |
| 2010-09-30 | $0.02B | $0.01B | 50.00% |
| 2010-06-30 | $0.03B | $0.01B | 48.00% |
| 2010-03-31 | $0.03B | $0.01B | 48.00% |
| 2009-12-31 | $0.03B | $0.01B | 52.00% |
| 2009-09-30 | $0.03B | $0.01B | 50.00% |
| 2009-06-30 | $0.03B | $0.01B | 53.85% |
| 2009-03-31 | $0.03B | $0.02B | 55.56% |
| 2008-12-31 | $0.03B | $0.02B | 53.57% |
| 2008-09-30 | $0.03B | $0.02B | 57.14% |
| 2008-06-30 | $0.03B | $0.02B | 57.14% |
| 2008-03-31 | $0.03B | $0.02B | 57.14% |
| 2007-12-31 | $0.03B | $0.02B | 57.14% |
| 2007-09-30 | $0.03B | $0.02B | 57.14% |
| 2007-06-30 | $0.03B | $0.02B | 57.14% |
| 2007-03-31 | $0.03B | $0.02B | 57.14% |
| 2006-12-31 | $0.03B | $0.02B | 57.14% |
| 2006-09-30 | $0.03B | $0.02B | 57.14% |
| 2006-06-30 | $0.03B | $0.02B | 57.14% |
| 2006-03-31 | $0.03B | $0.02B | 57.14% |
| 2005-12-31 | $0.03B | $0.02B | 57.14% |
| 2005-09-30 | $0.03B | $0.02B | 59.26% |
| 2005-06-30 | $0.03B | $0.02B | 59.26% |
| 2005-03-31 | $0.03B | $0.02B | 59.26% |
| 2004-12-31 | $0.03B | $0.02B | 59.26% |
| 2004-09-30 | $0.03B | $0.02B | 57.14% |
| 2004-06-30 | $0.03B | $0.02B | 57.14% |
| 2004-03-31 | $0.03B | $0.02B | 57.14% |
| 2003-12-31 | $0.03B | $0.02B | 57.14% |
| 2003-09-30 | $0.03B | $0.02B | 57.14% |
| 2003-06-30 | $0.03B | $0.02B | 57.14% |
| 2003-03-31 | $0.03B | $0.02B | 57.14% |
| 2002-12-31 | $0.03B | $0.02B | 57.14% |
| 2002-09-30 | $0.03B | $0.02B | 57.14% |
| 2002-06-30 | $0.03B | $0.02B | 57.14% |
| 2002-03-31 | $0.03B | $0.02B | 57.14% |
| 2001-12-31 | $0.03B | $0.02B | 57.14% |
| 2001-09-30 | $0.03B | $0.02B | 57.14% |
| 2001-06-30 | $0.03B | $0.02B | 57.14% |
| 2001-03-31 | $0.03B | $0.02B | 57.14% |
| 2000-12-31 | $0.03B | $0.02B | 57.14% |
| 2000-09-30 | $0.03B | $0.02B | 55.17% |
| 2000-06-30 | $0.03B | $0.02B | 53.33% |
| 2000-03-31 | $0.03B | $0.02B | 53.33% |
| 1999-12-31 | $0.03B | $0.02B | 53.33% |
| 1999-09-30 | $0.03B | $0.02B | 55.17% |
| 1999-06-30 | $0.03B | $0.02B | 57.14% |
| 1999-03-31 | $0.03B | $0.02B | 53.57% |
| 1998-12-31 | $0.03B | $0.01B | 51.85% |
| 1998-09-30 | $0.03B | $0.02B | 62.96% |
| 1998-06-30 | $0.03B | $0.02B | 62.96% |
| 1998-03-31 | $0.03B | $0.02B | 76.00% |
| 1997-12-31 | $0.02B | $0.02B | 87.50% |
| 1997-09-30 | $0.03B | $0.02B | 73.08% |
| 1997-06-30 | $0.03B | $0.02B | 68.97% |
| 1997-03-31 | $0.03B | $0.03B | 73.53% |
| 1996-12-31 | $0.04B | $0.03B | 64.10% |
| 1996-09-30 | $0.04B | $0.03B | 60.98% |
| 1996-06-30 | $0.04B | $0.03B | 59.52% |
| 1996-03-31 | $0.04B | $0.02B | 46.51% |
| 1995-12-31 | $0.04B | $0.02B | 44.19% |
| 1995-09-30 | $0.04B | $0.02B | 45.24% |
| 1995-06-30 | $0.04B | $0.02B | 43.90% |
| 1995-03-31 | $0.04B | $0.02B | 45.00% |
| 1994-12-31 | $0.04B | $0.02B | 46.15% |
| 1994-09-30 | $0.04B | $0.02B | 44.74% |
| 1994-06-30 | $0.04B | $0.02B | 45.95% |
| 1994-03-31 | $0.04B | $0.02B | 44.44% |
| 1993-12-31 | $0.04B | $0.02B | 44.44% |
| 1993-09-30 | $0.04B | $0.02B | 45.95% |
| 1993-06-30 | $0.04B | $0.02B | 45.95% |
| 1993-03-31 | $0.04B | $0.02B | 45.95% |
| 1992-12-31 | $0.04B | $0.02B | 44.44% |
| 1992-09-30 | $0.03B | $0.02B | 44.12% |
| 1992-06-30 | $0.03B | $0.01B | 42.42% |
| 1992-03-31 | $0.03B | $0.01B | 41.94% |
| 1991-12-31 | $0.03B | $0.01B | 43.33% |
| 1991-09-30 | $0.03B | $0.01B | 41.38% |
| 1991-06-30 | $0.03B | $0.01B | 44.44% |
| 1991-03-31 | $0.03B | $0.01B | 44.00% |
| 1990-12-31 | $0.02B | $0.01B | 43.48% |
| 1990-09-30 | $0.02B | $0.01B | 42.86% |
| 1990-06-30 | $0.02B | $0.01B | 40.00% |
| 1990-03-31 | $0.02B | $0.01B | 36.84% |
| 1989-12-31 | $0.02B | $0.01B | 33.33% |
| 1989-09-30 | $0.02B | $0.01B | 35.29% |
| 1989-06-30 | $0.02B | $0.01B | 33.33% |
| 1989-03-31 | $0.01B | $0.01B | 35.71% |
| 1988-12-31 | $0.01B | $0.01B | 41.67% |
| 1988-09-30 | $0.01B | $0.00B | 40.00% |
| 1988-06-30 | $0.01B | $0.00B | 44.44% |
| 1988-03-31 | $0.01B | $0.00B | 37.50% |
| 1987-12-31 | $0.01B | $0.00B | 37.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.197B | $0.039B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |